Shop Floor and Top Floor, Unite! - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Shop Floor and Top Floor, Unite!
Technology can solve enterprise-level problems.


Pharmaceutical Technology
Volume 33, Issue 5, pp. 14


Erik Greb
INTERPHEX was held in New York on Mar. 17-19, 2009. The pharmaceutical industry turns to this show for the latest innovations in pharmaceutical manufacturing equipment, but drug companies can benefit from the conference's presentations as well. Although production machinery was the main focus on the exhibit floor this year, two speakers provided practical advice about how to weather current economic challenges.

In their talk, Jayne Morris, principal engineer at Amgen (Thousand Oaks, CA), and Kim Van Camp, product manager at Emerson Process Management (Pittsburgh, PA), said that Amgen is using the information-technology infrastructure library (ITIL) to reduce cost and risk and to maximize productivity. ITIL is a worldwide standard that provides a framework of best practices for managing IT services through the IT service life cycle. Having used ITIL to manage its IT services, Amgen decided to apply aspects of it to automation, too, in hopes of improving service and change management.

Morris explained that when a company implements business processes such as service-level management and incident management using the ITIL framework, it can increase coordination, improve response time, resolve incidents quickly, and prevent incidents by sharing knowledge. Thus, ITIL focuses on continuous improvement and leads to more efficient automation-service delivery.

Although the presenters focused on automation and IT, they revealed one way of addressing enterprise-level concerns. Both underscored the idea that creativity can reveal the connections between seemingly separate things, and that ingenuity can lead to solutions for large problems.

Erik Greb is an assistant editor of Pharmaceutical Technology.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here